We are figuratively being held hostage by our 3rd party CDMO. Until the GMP passes specification testing we are stuck in limbo. There is no blame on the BOD from me for this.
So, what are peoples thoughts on the mc valuation if/when we pass and have a successful ph1 trial? I'm thinking $500m.
Ann: Further update on PAT-DX1 GMP manufacturing run, page-51
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.229M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.4¢ | 0.3¢ | $3.117K | 1.013M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 39 | 44343144 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 10764841 | 13 |
View Market Depth
| Last trade - 16.10pm 31/10/2024 (20 minute delay) ? |
| PAB (ASX) Chart |